{"id":"W2574678721","doi":"10.1111/dom.12832","title":"Randomized clinical trial comparing the efficacy and safety of treatment with the once‐weekly dipeptidyl peptidase‐4 ( <scp>DPP</scp> ‐4) inhibitor omarigliptin or the once‐daily <scp>DPP</scp> ‐4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Sitagliptin; Medicine; Sitagliptin Phosphate; Metformin; Internal medicine; Randomized controlled trial; Dipeptidyl peptidase-4 inhibitor; Confidence interval; Dipeptidyl peptidase-4; Adverse effect; Type 2 diabetes; Gastroenterology; Saxagliptin; Diabetes mellitus; Pharmacology; Endocrinology; Insulin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004073945,0.002149529,0.004967904,0.0005060445,0.0007057966,0.001318547,0.001367181,0.003042661,0.01133716],"category_scores_gemma":[0.005102083,0.001026873,0.0025682,0.0005753268,0.002154087,0.00147302,0.0006641045,0.003781595,0.00147638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001048764,"about_ca_system_score_gemma":0.002061814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001034145,"about_ca_topic_score_gemma":0.001673168,"domain_scores_codex":[0.9978404,0.001404133,0.0001567017,0.0003176941,0.0001161052,0.0001650091],"domain_scores_gemma":[0.9952118,0.001978624,0.0009951476,0.0004051261,0.0002917851,0.001117529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.994787,0.002412504,0.0001450642,0.0001405904,0.0003317743,0.000008398578,0.00001030417,0.0000717476,0.0003888466,0.00002453737,0.0001065798,0.001572579],"study_design_scores_gemma":[0.973161,0.02595519,0.0003004819,0.000009229068,0.0002103898,0.000007354603,0.000005068739,0.000149399,0.00007024913,0.00003908633,0.00008772988,0.000004716306],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9824349,0.00313748,0.001056692,0.0009728647,0.001299594,0.007546207,0.001401964,0.0001289262,0.002021424],"genre_scores_gemma":[0.9760786,0.001828519,0.002993386,0.001671964,0.001013203,0.01112003,0.001687882,0.00003072579,0.003575586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01133716,"threshold_uncertainty_score":0.03792655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02663838770768699,"score_gpt":0.2781004863912154,"score_spread":0.2514620986835284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}